Partenaires


Rechercher

Sur ce site

Sur le Web du CNRS


Accueil du site > Membres > Membres Permanents > Maîtres de Conférences > Gilles Crehange

Gilles Crehange

PU - Praticien Hospitalier

Centre Georges Francois Leclerc

Email : Gilles.Crehange u-bourgogne.fr

Projets :


Publications

Revues (10)

  • "Quelle imagerie pour la prise en charge de la rechute biochimique du cancer de la prostate : TEP ou IRM ?", Alexandre Cochet, Salim Kanoun, Olivier Humbert, Paul Walker, Luc Cormier, Gilles Crehange, François Brunotte, Cancer Radioth, 18 (5-6), 2014 lien sur HAL
  • "Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: Who\, when\, where and how?", Gilles Crehange, Mack Roach, Luc Cormier, Peiffert D., Alexandre Cochet, Chapet O., Supiot S., Cosset J.-M., Bolla M., Chung H.T., Cancer Radioth, 18 (5-6), 2014 lien sur HAL
  • "Pattern of occult nodal relapse diagnosed with 18F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy", Lépinoy Alexis, Alexandre Cochet, Cueff Adèle, Luc Cormier, Etienne Martin, Philippe Maingon, Jean François Bosset, François Brunotte, Gilles Crehange, Radiotherapy and Oncology, 111 (1), 2014 lien sur HAL
  • "In-vivo metabolic characterization of healthy prostate and orthotopic prostate cancer in rats using proton magnetic resonance spectroscopy at 4.7 T.", Paul Walker, Peggy Provent, Xavier Tizon, Gilles Crehange, Olivier Duchamp, François Brunotte, Philippe Genne, Acta Radiologica 54, 1(2013) 121-126, 2013 lien sur HAL
  • "Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy.", Gilles Crehange, Devan Krishnamurthy, Cunha J Adam, Barby Pickett, John Kurhanewicz, I-Chow Hsu, Gottschalk Alexander R, Katsuto Shinohara, Mack Roach, Jean Pouliot, Radiother Oncol, 109, 2, 246-50, 2013 lien sur HAL
  • "Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer.", Gilles Crehange, Céline Mirjolet, Mélanie Gauthier, Etienne Martin, Gilles Truc, Karine Peignaux-Casasnovas, Caroline Azelie, Franck Bonnetain, Suzanne Naudy, Philippe Maingon, Radiother Oncol, 103, 2, 244-6, 2012 lien sur HAL
  • "Classification of prostate magnetic resonance spectra using Support Vector Machine", Sébastien Parfait, Paul Walker, Gilles Crehange, Xavier Tizon, Johel Miteran, Biomedical Signal Processing and Control (2011) 1-8, 2011 lien sur HAL
  • "EARLY CHOLINE LEVELS FROM 3-TESLA MR SPECTROSCOPY AFTER EXCLUSIVE RADIATION THERAPY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER ARE PREDICTIVE OF PLASMATIC LEVELS OF PSA AT 1 YEAR", Gilles Crehange, Philippe Maingon, Mélanie Gauthier, Sébastien Parfait, Alexandre Cochet, Céline Mirjolet, Franck Bonnetain, Luc Cormier, François Brunotte, Paul Walker, International Journal of Radiation Oncology Biology Physics 81, 4(2011) E407-413, 2011 lien sur HAL
  • "Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.", Gilles Crehange, Sébastien Parfait, Mélanie Liegard, Philippe Maingon, Douraied Ben Salem, Alexandre Cochet, Mathilde Funes De La Vega, Luc Cormier, Franck Bonnetain, Céline Mirjolet, François Brunotte, Paul Walker, International Journal of Radiation Oncology - Biology - Physics 80, 4 (2011) 1087-94, 2011 lien sur HAL
  • "Tumor Volume and Metabolism of Prostate Cancer Determined by Proton Magnetic Resonance Spectroscopic Imaging at 3T Without Endorectal Coil Reveal Potential Clinical Implications in the Context of Radiation Oncology", Gilles Crehange, Sébastien Parfait, Mélanie Liegard, Philippe Maingon, Douraied Ben Salem, Alexandre Cochet, Mathilde Funes De La Vega, Luc Cormier, Franck Bonnetain, Céline Mirjolet, François Brunotte, Paul Walker, International Journal of Radiation Oncology*Biology*Physics, Elsevier, In press 2010 lien sur HAL

Conférences internationales (9)

  • "Prostate Metabolism After the Completion of Exclusive Radiation Is More Depleted After Seeds Brachytherapy Compared to External Beam Radiation Therapy for Prostate Cancer Patients", Gilles Crehange, Mélanie Gauthier, Alexandre Cochet, Etienne Martin, Céline Mirjolet, François Brunotte, Philippe Maingon, Paul Walker, 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Boston : États-Unis, 2012 lien sur HAL
  • "Multiparametric MRI-based Dosimetric Parameters Best Predict Short-term Time Course of PSA After Iodine 125 Permanent Prostate Implantation for Localized Prostate Cancer", Paul Walker, Philippe Maingon, Magali Quivrin, Céline Mirjolet, Damien Sottier, Etienne Martin, Gilles Crehange, 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Boston : États-Unis, 2012 lien sur HAL
  • "In vivo characterisation of orthotopic prostate tumor and healthy rat prostate metabolism using 1H MRS at 4.7 T", Xavier Tizon, Peggy Provent, Sébastien Parfait, Gilles Crehange, Johel Miteran, Philippe Genne, François Brunotte, Olivier Duchamp, Paul Walker, ISMRM 2010, Stockholm, Sweden, 2010
  • "Prostate cancer metabolism assessment by proton magnetic resonance spectroscopy (1H-MRS) and high resolution magic angle spinning spectroscopy (1H-HRMAS) in experimental rat models", Peggy Provent, Paul Walker, Xavier Tizon, Nicolas Hoffman, Sébastien Parfait, Véronique Lemaitre, V. Bari, Johel Miteran, Alain Tabard, Gilles Crehange, Olivier Duchamp, Philippe Genne, AACR 100th Annual Meeting 2009, Denver, United States, 2010
  • "Absolute Quantification in 1H MRSI of the Prostate at 3T", Paul Walker, Gilles Crehange, Sébastien Parfait, Alexandre Cochet, Philippe Maingon, Luc Cormier, François Brunotte, ISMRM Annual Meeting 2010, Stockholm, Sweden, 2010
  • "Correlation between clinical prognostic factors and MR spectroscopy-based biomarkers determined at 3.0 T without endorectal coils for patients with localised prostate cancer", Gilles Crehange, Sébastien Parfait, Mélanie Liegard, Douraied Ben Salem, Philippe Maingon, Mathilde Funes De La Vega, Luc Cormier, Franck Bonnetain, François Brunotte, Paul Walker, EORTC-NCI-ASCO Annual Meeting 2009, Vol. 7 (Issue 4), pp. 14-15, Brussels, Belgium, October 2009 lien sur HAL
  • "Classification of prostate magnetic resonance spectra", Sébastien Parfait, Paul Walker, Gilles Crehange, François Brunotte, Johel Miteran, IFCS 2009, Dresde, Allemagne, March 2009
  • "MR-based biomarkers in the diagnosis and the evaluation of the therapeutic response to radiotherapy (ETRR) in prostatic carcinoma (PCa): Implementation of clinical and experimental approaches", Gilles Crehange, Paul Walker, Sébastien Parfait, Philippe Maingon, Alexandre Cochet, François Brunotte, Xavier Tizon, Peggy Provent, Olivier Duchamp, 45th Annual Meeting of the American-Society-of-Clinical-Oncology, Orlando : États-Unis, 2009 lien sur HAL
  • "Temozolomide and radiotherapy antitumor efficacy evaluation with magnetic resonance imaging and proton magnetic resonance spectroscopy in human glioma models in nude rats", Xavier Tizon, Paul Walker, Sébastien Parfait, Johel Miteran, Gilles Crehange, Philippe Maingon, Nicholas Hoffman, Philippe Genne, Olivier Duchamp, 20th Meeting of the European-Association-for-Cancer-Research, Lyon : France, 2008 lien sur HAL

Conférences nationales (1)

  • "Classification of Prostate Cancer Magnetic Resonance Spectra", Sébastien Parfait, Paul Walker, Xavier Tizon, Gilles Crehange, Peggy Provent, François Brunotte, Olivier Duchamp, Johel Miteran, ONCOTRANS 2009, Nancy, France, March 2009

Thèses (1)

  • "Evaluation de la spectroscopie du proton par RMN à 3 Tesla sans antenne endorectale chez les patients présentant un cancer de prostate localisé traité par radiothérapie exclusive", Gilles Crehange, 2011 lien sur HAL

Derniers billets publiés


Archives


LE2I - Laboratoire Electronique, Informatique et Image | webmestre : Antoine Trapet | info légales | logo SPIP 2